Gene expression-based machine learning approach to predict immunotherapy response and survival in patients with advanced cancer.
Zheng Zhang(Shanghai Changzheng Hospital), Zhisong He(Peking University), Xuanjun Guo(Peking University Cancer Hospital), Yiqun Zhang(Baylor College of Medicine), Dongliang Wang(Hebei Medical University), Qi Tang(Tianjin University), Qiming Zhou(Tsinghua University), Yantong Hao, Zhihua Pei(Huazhong Agricultural University), Xianyun Wang(Hebei Medical University), Aixiang Wang(Peking University), Kaiwei Yang(Peking University)
Cited by 2
Related Papers
Exosomes decorated with a recombinant SARS-CoV-2 receptor-binding domain as an inhalable COVID-19 vaccine
|Nature Biomedical Engineering|2022|267
Validation of human periodontal ligament‐derived cells as a reliable source for cytotherapeutic use
|Journal Of Clinical Periodontology|2010|209
Platelet membrane and stem cell exosome hybrids enhance cellular uptake and targeting to heart injury
|Nano Today|2021|150
Prevalence and risk of atrial fibrillation in China: A national cross-sectional epidemiological study
|The Lancet Regional Health - Western Pacific|2022|137